Objectives. To evaluate criterion and construct validity of the self-administered comorbidity questionnaire (SCQ) in patients with AS.
Introduction
AS is a chronic inflammatory disease of the sacroiliac joints and spine that can lead to substantial functional limitations [14] . In addition to articular symptoms, extra-articular manifestations related to the concept of SpA, comprising uveitis, psoriasis and IBD, occur frequently and contribute to the burden of disease. Moreover, patients with AS can develop comorbidities, which are also seen in the general population. Some of these comorbidities, including cardiovascular disease and osteoporosis, occur more frequently in AS than in the general population, probably as a result of the inflammatory pathophysiological process [58] .
It has been recognized that comorbidities can affect the detection, prognosis, therapy but also outcome of a single condition at any moment [914] . Literature on the role of comorbidities on patient outcomes in AS is scarce. Notwithstanding, available studies showed that comorbidity contributes to physical function, HRQoL and work participation outcomes [2, 15, 16] . Therefore, comorbidity should be considered as a confounder, effect-modifier or predictor in studies on outcomes in AS. Several instruments have been developed to identify and measure comorbidities for use in research [1719] . However, no comorbidity instrument has been evaluated for use in outcome studies in AS, hampering the influence of comorbidities on health status.
The self-administered comorbidity questionnaire (SCQ) is a generic, self-report questionnaire with 13 common medical conditions, developed to adjust for the impact of comorbidity on functional status [19] . The SCQ was validated in 170 inpatients from medical and surgical care units and was found to be an efficient instrument to assess comorbid conditions in clinical and health services research among patients with a broad range of the underlying diseases [19] . The clinimetric properties of the SCQ have also been validated in some rheumatic diseases [20, 21] . In AS, the SCQ has been used as an instrument to measure comorbidity [2] , but aspects of validity have never been evaluated.
The aim of the present study was to assess criterion and construct validity of the SCQ in a prevalence cohort of patients with AS. We hypothesized that a valid comorbidity index, which aims to adjust health status for the influence of comorbidity, should have the following properties: capture similar comorbidities as documented in the medical records (criterion validity); correlate with other existing measures of comorbidity, in particular with those relating comorbidities to health status (construct validity); correlate with age and to some extent with HRQoL, physical function and work participation, but less with AS-related disease activity (construct validity); and behave as an independent contributor, confounder or effect-modifier on physical function, HRQoL and work disability (construct validity).
Patients and methods

Patients
The present study used data from the Outcome in AS International Study (OASIS), a longitudinal observational prevalence cohort including 217 consecutive outpatients with AS from the Netherlands, Belgium and France that has started in 1996 [22] . Clinical data have been collected biannually for up to 12 years. Before each study visit, a postal questionnaire including all instruments was sent to the patients' homes. The patients returned the questionnaires to the researchers at the study visit and, if applicable, patients were asked to complete missing items. In Year 8 of follow-up (Year 2005), the SCQ was added to the questionnaire. For the present analysis, the SCQ data of patients from the Netherlands (n = 87) and Belgium (n = 11), who were still participating, were used. French patients were excluded, because no medical records outside the rheumatology department could be retrieved. The OASIS study and subsequent analyses were approved by the ethics committees of the participating centres in the Netherlands, Belgium and France and informed consent was obtained from all subjects.
Study instrument
The SCQ asks patients to indicate if they suffer at this moment from 13 additional medical conditions that might have impact on functioning [19] . The conditions are: heart disease, high blood pressure, lung disease, diabetes, ulcer or stomach disease, kidney disease, liver disease, anaemia or other blood disease, cancer, depression, OA, back pain, RA (in the Dutch version this was translated as 'chronic rheumatic disease') and an option to add three other non-specified medical problems. OA and RA are listed separately, but are scored as one. The patient is asked to indicate for each condition if it is present (yes/no), is currently treated (yes/no) and/or imposes functional limitations (yes/no). Every 'yes' is given one point contributing to a maximum score of 45. For the present study, a modified version of the SCQ (mSCQ) was also evaluated by removing the items related to rheumatic conditions (chronic rheumatic disease, back pain and OA), because these conditions were assumed to be difficult to distinguish from the index disease and because patients likely cannot separate the functional impact of these diseases from the impact of AS. The mSCQ is scored similarly as the SCQ, but due to fewer items the score ranges from 0 to 39.
Criterion validity
Criterion validity is the degree to which the scores of an instrument are an adequate reflection of the 'gold standard' [23] . We studied this by evaluating the agreement between the self-reported comorbidities and current treatment with data from the medical records.
The comorbidity and treatment data were extracted from the medical records by two independent chart extractors, who were blinded to the SCQ data, using a predefined list of comorbidities. The comorbidities were extracted for each year between 1996 and 2005, or were considered as 'present before 1996'. A condition was considered as present when any physician diagnosis or disease specific medication was noted in the record (e.g. diabetes was identified as present when insulin was noted). Reports from X-rays were checked on the presence of OA (both of the spine and peripheral joints), and scored as present if the radiologist clearly reported it. Each of the extractors dealt with about half the sample. To assess intra-and inter-observer reliability of the data acquisition, each chart extractor reviewed both a random sample of 10 charts a second time with a one month interval and a random sample of 10 charts previously reviewed by the other extractor.
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Construct validity
Construct validity is the degree to which the scores of an instrument are consistent with hypotheses, e.g. with regard to positive or absent relationships with scores of other instruments [23] .
First, we hypothesized that the SCQ should correlate with other existing measures of comorbidity: the Charlson index and the MichaudWolfe index. The Charlson index (range 033) is the most extensively applied record-based comorbidity index and was developed to predict mortality [17] . The Charlson index consists of 19 conditions with specific weighing for each condition based on the mortality-risk. The MichaudWolfe index (range 09) is originally a self-reported comorbidity index including 11 weighted conditions and was developed for outpatients with different rheumatic diseases, to predict several outcomes including functional status and health resource utilization [24] . For the present study, both the Charlson and the MichaudWolfe index were calculated using data retrieved from the medical records. Intra-and inter-observer reliability of the chart extractors to calculate these scores was assessed.
Second, we hypothesized that the SCQ should correlate with age, at least weakly with generic as well as ASspecific HRQoL, physical function and work disability, but not with AS-related disease activity, because the index is meant to measure diseases other than the index disease. Physical function was measured with the BASFI [25] . Generic HRQoL was measured with the SF-36 (Dutch RAND-36 version 1.0) [26] of which the SF-36 physical component summary score (PCS) and the SF-36 mental component summary score (MCS) were calculated using norm-based data from the Dutch and US population (mean 50, S.D. 10) [27, 28] . AS-specific HRQoL was measured with the AS Quality of Life (ASQoL) [29] . Disease activity was measured with the BASDAI [30] , the AS Disease Activity Score (ASDAS) [31] , CRP, ESR, and both the patient and physician global assessment score. Work status was included in the demographic questions and asked whether patients had withdrawn from labour force due to (partial) work disability. To compare the SCQ with medical-record based comorbidity indices, correlations with all constructs were also calculated for the Charlson and MichaudWolfe indices.
Third, we hypothesized that comorbidity as measured with the SCQ should behave as an independent contributor, confounder or effect-modifier on physical function (BASFI), HRQoL (SF-36 PCS) and work disability. This was tested by computing the relative contribution of the SCQ to these outcomes in a multivariable regression analysis while adjusting for clinicaldemographic characteristics. For comparison, the same analyses were repeated for the Charlson and MichaudWolfe indices.
Statistical analysis
Descriptive statistics were used to describe demographic data and the frequency of reported comorbidities in the SCQ and in the medical records.
Criterion validity
Agreement between the patients' answers on the SCQ and data from the medical records was calculated with kappa statistics. For conditions with a prevalence of 0% or 100% documented by either SCQ or medical records, kappa statistics could not be calculated. Kappa-values of 00.20 indicate slight agreement; 0.210.40, fair agreement; 0.410.60, moderate agreement; 0.610.80, substantial agreement; and 0.811.0, almost perfect agreement [32] . The intra-and inter-observer reliability of the data acquisition from the medical records was explored by calculating kappa statistics for the items 'condition present' and 'condition treated' for each condition of the SCQ.
Construct validity
The correlations between the comorbidity scores and continuous outcomes were evaluated using Spearman's correlation coefficients and the association between comorbidity and work disability was calculated using odds ratios (OR) (95% CI). Correlation coefficients of 0.210.40 were qualified as weak, 0.410.75 as moderate and above 0.75 as strong [9] . The intra-and inter-observer reliability of the data retrieved by the chart extractors used for computing the Charlson and MichaudWolfe indices was assessed with two-way mixed model intraclass correlation coefficients. A value of >0.60 represents good reliability; >0.8, very good reliability; and >0.90, excellent reliability. The relative contribution of comorbidity (SCQ, mSCQ, Charlson index, MichaudWolfe index) to variations in physical function (BASFI), HRQoL (SF-36 PCS) and work disability was tested in univariable followed by multivariable regression analysis while controlling for clinical-demographic and disease characteristics, if appropriate. The comorbidity score was entered first and kept in the model. The other variables were entered (if P < 0.10 in univariable analysis) and removed (if P > 0.05 in multivariable analysis) hierarchically (forward regression method). All possible interactions between the variables were tested in separate analyses. Statistical analyses were performed using SPSS 18.0.
Results
Patient characteristics
All 98 patients completed all items of the SCQ. Characteristics of the patients are presented in Table 1 . The sample was similar to the 217 patients included in OASIS at baseline in terms of age, gender, symptom duration, disease activity and function (data not shown) [22] . The mean SCQ-score was 5.4 (S.D. 4.1) and the mean score for the mSCQ was 2.9 (S.D. 3.0). Table 2 shows the patients' responses on the SCQ and the frequency of comorbidities extracted from the medical records. Eighty-seven (88.8%) patients reported at least one comorbidity, of which 64 (65.3%) patients reported at least one non-rheumatic condition. With respect to the rheumatic conditions, 67 (68.4%) patients reported to have 'back pain', 19 (19.4%) patients reported 'OA' and Within the last group, 11 (73.3%) patients had a history of peripheral arthritis, compared to 48 of 83 (57.8%) patients who indicated not to suffer from a chronic rheumatic disease (P = 0.26). At least one additional condition was reported by 43 (43.9%) patients and included, among others, IBD (n = 10), uveitis (n = 5), neurologic diseases (n = 7) and psoriasis (n = 1).
Criterion validity Table 2 also shows the agreement (k) between patients' answers on the SCQ and medical records data. The agreement varied from slight (depression, ulcer or stomach disease and OA) to substantial or perfect agreement (heart disease, hypertension, diabetes, kidney-disease, anaemia and cancer).
The reliability analyses of the data acquisition from the medical records showed that both the intra-and interobserver reliability for the specific items in the SCQ was substantial to almost perfect (k 0.641.00), except for OA (k 0.26 and 0.49 for intra-and inter-rater reliability, respectively). Table 3 shows the correlations of the SCQ and mSCQ with the Charlson index and MichaudWolfe index. The correlations between the instruments were low to moderate (0.240.57), but better for the mSCQ compared with the SCQ and better with the MichaudWolfe index compared with the Charlson index. The intra-and interobserver reliability of data acquisition to calculate the Charlson and MichaudWolfe indices was very good (0.85, 95% CI 0.650.94) to excellent (0.91, 95% CI 0.780.96). Table 3 also shows the correlations with the other constructs. All comorbidity indices correlated with age. The SCQ and mSCQ correlated both moderately with HRQoL and physical function, whereas for the Charlson and MichaudWolfe indices only weak correlations were found. The SCQ correlated weakly with some measures of disease activity, whereas the mSCQ did not. Strong associations were found between SCQ, mSCQ and the MichaudWolfe index with work disability.
Construct validity
The results of the regression analyses are shown in Tables 4, 5 linearity were checked and were met. In multivariable analysis, the SCQ and mSCQ were significantly associated with the BASFI and the SF-36 PCS, whereas the Charlson and MichaudWolfe indices were not. A significant interaction between disease activity and both SCQ and mSCQ with work disability was found; therefore the models were stratified for level of disease activity in multivariable analysis. In patients with low disease activity (BASDAI <4, n = 46), comorbidity (SCQ or mSCQ) was the only variable which was significantly associated with work disability. In patients with high disease activity (BASDAI 5 4, n = 37), work disability was not associated with comorbidity. The MichaudWolfe index and Charlson index were not associated with work disability in multivariable analysis.
Discussion
The present study shows that the SCQ has evidence for validity in an outpatient population with long-standing AS. Agreement between self-reported comorbidities and comorbidities retrieved from the medical records was moderate to almost perfect for the non-rheumatic conditions, except for ulcer and stomach disease and for depression, which were both more frequently reported by patients than retrieved from the medical records. Possibly, patients may have reported a disease based on symptoms they are experiencing without having an official diagnosis by a physician or patients may have been diagnosed by a general practitioner or, less likely, by a physician working outside the region of our hospitals. With respect to the rheumatic conditions, the agreement for OA was low in both directions, which means that also some patients were unaware that they suffered from OA, although it was stated in the medical record. Agreement for low back pain and chronic rheumatic disease was not calculable as by default patients with AS were considered to have these conditions. Partly, patients might have ignored the instruction to report only 'additional' diseases. For chronic rheumatic disease, the presence of peripheral arthritis did not influence this reporting.The low criterion validity for the rheumatic items supports our hypothesis that it is difficult for AS patients to distinguish the index disease and its impact on health outcomes from other rheumatic conditions, and supports the proposal to remove these items when applying the SCQ in AS. Overall, the agreement observed in our study was largely comparable with that reported in the original validation study [19] . Other studies also confirmed that a selfreported instrument is a reliable data source for assessment of comorbidities [33, 34] .
The SCQ has two important characteristics. First, it is a self-report questionnaire, which offers a feasible method to collect comorbidity data. Second, the SCQ includes functional limitations due to the comorbidity, which may better predict HRQoL and physical function than medical records data. These two characteristics make the SCQ a promising instrument to adjust commonly used outcomes in AS for the impact of comorbidities. The correlation of the original SCQ with the MichaudWolfe index was, as expected, stronger than with the Charlson index, The MichaudWolfe index was developed to understand the influence of comorbidity on several health outcomes, whereas the Charlson index was developed to predict mortality and therefore does not necessarily include diseases with high impact on physical function and HRQoL. Both correlations improved when excluding the rheumatic items from the SCQ. Nevertheless, the correlations between the comorbidity indices were not perfect, which is most likely due to the different conditions included in the different indices and to the additional points, which can be scored in the SCQ based on self-perceived impact 
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Validity of the SCQ in AS on function. The correlation between the mSCQ and Charlson index was comparable with reports from the original study of the SCQ (r = 0.32 vs r = 0.36 in our study) [19] . Our a priori hypotheses on the correlations with other constructs were largely met and confirmed correlation of both the SCQ and mSCQ with physical function, HRQoL, and work disability. The SCQ but not the mSCQ showed a weak correlation with measures of AS-related disease activity. This supports a better validity for measuring comorbidity with the mSCQ. It is well recognized that the experienced functional limitations due to AS are partly influenced by disease activity [35] , explaining the weak correlation between the SCQ and AS-related disease activity when keeping the rheumatic items and its impact on function into the questionnaire. The adequate construct validity of the mSCQ found in de present study is consistent with a previous study evaluating an adapted version of the SCQ in patients with early inflammatory arthritis [20] . A study in patients with SLE and SSc, however, showed that these patients could not distinguish comorbidities from their index disease, which confirms the importance of removing comorbidities with overlapping symptoms with the index disease from the questionnaire [21] . Importantly, the SCQ and mSCQ had a significant independent contribution to HRQoL, physical function and work disability, while this was neither the case for the Charlson index nor for the MichaudWolfe index. Again, the additional questions on functional limitations for each condition in the SCQ may explain the stronger association with physical function and HRQoL. Interestingly, the SCQ and mSCQ correlated only with work disability in patients with low disease activity. Apparently, in these patients comorbidity and not the impact of AS on function was the main reason for withdrawal from work.
Another interesting observation was that a small a proportion of patients reported spontaneously extra-articular manifestations (uveitis, psoriasis, IBD) in the open item section of the SCQ. These manifestations are part of the disease and should therefore not be considered as comorbidities, but this might have been confusing for patients. However, these concept-related manifestations may also influence health outcomes, in particular because they have a high prevalence in patients with AS [3638] . An AS-specific questionnaire, including both comorbidities and SpA concept-related manifestations, might therefore be preferred above a generic questionnaire on comorbidities only, but future studies are needed to investigate this.
Some limitations of our study need to be addressed. First, most comorbid conditions were not prevalent and the large 95% CIs of the kappa statistics found in the present study may have been due to the low prevalence. Second, because the SCQ was administered in year 8 of follow-up of the OASIS-study, 64 out of 162 Dutch and Belgian patients who were included at baseline, were lost to follow up. We expect that the loss to follow up will not have a significant influence on the validity assessment. Third, our population with long-standing AS may not be representative for all patients with AS. Therefore, the results should be confirmed in patients with early AS. Fourth, the MichaudWolfe index was not yet developed at the time the patients in the present study completed the SCQ and, therefore, this score was retrospectively calculated based on medical records data. This hampers a formal comparison of the SCQ and MichaudWolfe index. Fifth, we compared the SCQ items with medical record retrieved comorbidities. Medical records may have their limitations and quality of documentation can vary. We did not include documentation from sources outside the hospital, unless clearly stated in the medical records of the patient. This may have underestimated the accuracy of self-report. Sixth, neither pilot testing of the questionnaire prior to its use nor test-retest reliability of the SCQ was done. For the original English study, pilottesting was performed and a good test-retest reliability of the SCQ was reported. We did not expect differences in the translated Dutch version for AS, since the medical terms used in the questionnaire are also commonly used by patients and lay persons in our countries.
In summary, our study showed that patients with AS can accurately report most comorbidities included in the SCQ and confirms that the SCQ correlates well with physical function and HRQoL in patients with AS. The validity of the SCQ improved after removing rheumatic items from the questionnaire. It should be realized that SpA conceptrelated manifestations are not included in this index, although they may have an important additional impact on health status.
Rheumatology key messages
. The SCQ has evidence for validity in patients with AS. . Removing the rheumatic items from the SCQ improves validity of the instrument in AS. . Comorbidity is independently associated with function, HRQoL and work disability in AS.
